ALLR Allarity Therapeutics, Inc.
Price Chart
Executive Summary
Allarity Therapeutics filed an amendment to its S-3 shelf registration to update the auditor consent, with no changes to the prospectus. The filing is administrative and does not disclose new offering terms, size, or pricing. This maintains the company's ability to issue securities on a delayed or continuous basis.
Actionable Insight
Monitor for future prospectus supplements or 8-K filings that may disclose actual offering terms, size, and use of proceeds. The current amendment is routine and does not trigger immediate trading implications.
Key Facts
- Filing is an exhibits-only amendment to a previously filed S-3 shelf registration (File No. 333-293420).
- Purpose is to update the auditor consent (Exhibit 23.2) from Wolf & Company, P.C.
- No changes were made to the prospectus or offering details; no offering size, share count, or pricing disclosed.
- Original S-3 was filed on February 12, 2026, and allows for future issuance of unspecified amounts of securities.
Financial Impact
No immediate financial impact — no capital raised in this filing. Potential for future dilution if shares are issued under the shelf.
Risk Factors
- Future ATM or follow-on offerings could lead to significant dilution given the small market cap ($22M).
- Lack of disclosed offering terms increases uncertainty around timing and scale of potential capital raises.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3/A Filing (Primary) | 0001213900-26-047385 |
| Document: ea028739601ex23-2.htm | 0001213900-26-047385 |
| Document: 0001213900-26-047385-index-headers.html | 0001213900-26-047385 |
| Document: 0001213900-26-047385-index.html | 0001213900-26-047385 |
| Document: 0001213900-26-047385.txt | 0001213900-26-047385 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 11, 2026
4w ago
|
3
| $1.68 $1.43 | ▼ −14.88% | ▼ −14.80% | $1.43 (−14.88%) |
|
May 8, 2026
5w ago
|
Press Release
| $1.55 $1.51 | ▼ −2.58% | ▼ −4.04% | $1.43 (−7.74%) |
|
May 6, 2026
5w ago
|
8-K
| $1.48 $1.52 | ▲ +2.70% | ▲ +1.57% | $1.43 (−3.38%) |
|
Apr 27, 2026
6w ago
|
Press Release
| $1.37 $1.25 | ▼ −8.76% | ▼ −9.16% | $1.43 (+4.38%) |
|
Apr 27, 2026
7w ago
|
EFFECT
| $1.37 $1.25 | ▼ −8.76% | ▼ −9.16% | $1.43 (+4.38%) |
|
Apr 24, 2026
7w ago
|
S-3/A
| $1.34 $1.35 | ▲ +0.75% | ▼ −0.16% | $1.43 (+6.72%) |
|
Apr 22, 2026
7w ago
|
8-K
| $1.40 $1.39 | ▼ −0.81% | ▼ −0.87% | $1.43 (+2.14%) |
|
Apr 1, 2026
10w ago
|
8-K
| $1.13 $1.15 | ▲ +1.77% | ▼ −2.00% | $1.43 (+26.55%) |
|
Mar 31, 2026
10w ago
|
Press Release
| $1.09 $1.16 | ▲ +6.42% | ▲ +2.48% | $1.43 (+31.19%) |
|
Mar 6, 2026
14w ago
|
Press Release
| $1.24 $1.26 | ▲ +1.61% | ▲ +3.14% | $1.43 (+15.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access